1.1k total citations 98 papers, 834 citations indexed
About
Morris Pj is a scholar working on Transplantation, Surgery and Immunology.
According to data from OpenAlex, Morris Pj has authored 98 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Transplantation, 41 papers in Surgery and 15 papers in Immunology. Recurrent topics in Morris Pj's work include Renal Transplantation Outcomes and Treatments (36 papers), Organ Transplantation Techniques and Outcomes (17 papers) and Organ Donation and Transplantation (11 papers). Morris Pj is often cited by papers focused on Renal Transplantation Outcomes and Treatments (36 papers), Organ Transplantation Techniques and Outcomes (17 papers) and Organ Donation and Transplantation (11 papers). Morris Pj collaborates with scholars based in United Kingdom, United States and Germany. Morris Pj's co-authors include Paul McShane, A. Ting, Margaret J. Dallman, H Reece-Smith, JM Hopkin, Derek W. R. Gray, Chapman, Warren Johnson, Nathan F. Johnson and J. L. Anderton and has published in prestigious journals such as Blood, Diabetes and Transplantation.
In The Last Decade
Morris Pj
94 papers
receiving
766 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Morris Pj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Pj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Pj more than expected).
This network shows the impact of papers produced by Morris Pj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Pj. The network helps show where Morris Pj may publish in the future.
Co-authorship network of co-authors of Morris Pj
This figure shows the co-authorship network connecting the top 25 collaborators of Morris Pj.
A scholar is included among the top collaborators of Morris Pj based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Morris Pj. Morris Pj is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Pj, Morris. (1997). Transplantation in the 21st century.. PubMed. 58. S51–5.6 indexed citations
2.
Saitovitch, David, et al.. (1995). Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.. PubMed. 27(1). 117–8.9 indexed citations
3.
Hopkin, JM, et al.. (1989). The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation.. PubMed. 47(3). 558–60.44 indexed citations
4.
Pj, Morris, et al.. (1989). Induction of immunological unresponsiveness using recipient cells transfected with donor class I or class II MHC genes.. PubMed. 21(1 Pt 1). 477–477.4 indexed citations
5.
Pj, Morris, et al.. (1987). Arterial assessment before carotid endarterectomy: current practice in Great Britain and Ireland.. PubMed. 28(5). 516–9.3 indexed citations
6.
Pj, Morris, et al.. (1987). The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.. PubMed. 44(6). 849–52.70 indexed citations
7.
Pj, Morris, et al.. (1987). The effect of pretreatment with a single cloned donor class I gene product on cardiac allograft survival in mice.. PubMed. 44(5). 719–21.2 indexed citations
8.
Ting, A. & Morris Pj. (1987). HLA matching in transfused, cyclosporine-treated patients at Oxford.. PubMed. 235–8.2 indexed citations
9.
Pj, Morris, et al.. (1987). Class I antigen pretreatment prolongs allograft survival in mice by induction of suppressor cells.. PubMed. 19(4). 3459–60.1 indexed citations
10.
Cranston, David, et al.. (1987). Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.. PubMed. 19(1 Pt 1). 505–505.2 indexed citations
11.
Pj, Morris. (1982). Some experimental and clinical studies of Cyclosporin A in renal transplantation.. PubMed. 14(3). 525–8.2 indexed citations
12.
Pj, Morris, et al.. (1981). A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog.. PubMed. 13(1 Pt 1). 397–401.9 indexed citations
13.
Pj, Morris, et al.. (1980). Experimental transplantation of fetal pancreas and isolated islets in the rat: studies of donor pretreatment and recipient immunosuppression.. PubMed. 12(4 Suppl 2). 186–9.3 indexed citations
Kettlewell, M G W, et al.. (1979). Immunology and the surgeon.. PubMed. 11. 1–23.
16.
Pj, Morris, et al.. (1979). Effect of splenectomy alone and in combination with antilymphocyte serum on renal allograft rejection in the rat.. PubMed. 27(6). 389–91.3 indexed citations
17.
Pj, Morris, et al.. (1979). Reversal of postoperative immunosuppression in man by vitamin A.. PubMed. 149(5). 658–62.36 indexed citations
18.
Pj, Morris, et al.. (1977). Cystic changes in the liver following experimental intraportal pancreatic islet transplantation.. Transplantation. 23(2). 182–5.9 indexed citations
19.
Kincaid-Smith, P, et al.. (1969). Biopsy features of early acute rejection in cadaveric renal grafts.. PubMed. 1(1). 287–9.7 indexed citations
20.
Jf, Burke, et al.. (1965). Specific antibody against selective marked malignant cells.. PubMed. 16. 98–100.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.